{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:47:56Z","timestamp":1788263276668,"version":"build-2803163510"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["SE 581\/33-1"],"award-info":[{"award-number":["SE 581\/33-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.humimm.2024.110792","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:22:58Z","timestamp":1711732978000},"page":"110792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of HLA-G in tumors and upon COVID-19 infection"],"prefix":"10.1016","volume":"85","author":[{"given":"Barbara","family":"Seliger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4952","key":"10.1016\/j.humimm.2024.110792_b0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/iji.12513","article-title":"HLA-G: Function, polymorphisms and pathology","volume":"48","author":"Arnaiz-Villena","year":"2021","journal-title":"Int. J. Immunogenet."},{"issue":"11","key":"10.1016\/j.humimm.2024.110792_b0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/1878-0261.12119","article-title":"Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients","volume":"11","author":"Tronik-Le Roux","year":"2017","journal-title":"Mol. Oncol."},{"issue":"8","key":"10.1016\/j.humimm.2024.110792_b0020","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.166.8.5018","article-title":"HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis","volume":"166","author":"Riteau","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/gene.2009.74","article-title":"The genetic structure of 3'untranslated region of the HLA-G gene: Polymorphisms and haplotypes","volume":"11","author":"Castelli","year":"2010","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/humupd\/dmi048","article-title":"HLA-G in human reproduction: aspects of genetics, function and pregnancy complications","volume":"12","author":"Hviid","year":"2006","journal-title":"Hum. Reprod. Update"},{"issue":"Database issue","key":"10.1016\/j.humimm.2024.110792_b0035","doi-asserted-by":"crossref","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: Allele variant databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.humimm.2024.110792_b0040","doi-asserted-by":"crossref","first-page":"D1053","DOI":"10.1093\/nar\/gkac1011","article-title":"The IPD-IMGT\/HLA database","volume":"51","author":"Barker","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.humimm.2024.110792_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-065X.1997.tb00945.x","article-title":"Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors","volume":"155","author":"Colonna","year":"1997","journal-title":"Immunol. Rev."},{"issue":"44","key":"10.1016\/j.humimm.2024.110792_b0055","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1073\/pnas.0605228103","article-title":"Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2\/LIR2\/ILT4\/CD85d)","volume":"103","author":"Shiroishi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9B","key":"10.1016\/j.humimm.2024.110792_b0060","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1111\/j.1582-4934.2009.00800.x","article-title":"Non-classical transcriptional regulation of HLA-G: an update","volume":"13","author":"Moreau","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.humimm.2024.110792_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0070","doi-asserted-by":"crossref","first-page":"e33395","DOI":"10.1371\/journal.pone.0033395","article-title":"MiRNA-mediated control of HLA-G expression and function","volume":"7","author":"Manaster","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcyt.2017.12.008","article-title":"An intriguing link between human leukocyte antigen G, T-regulatory cells and neutrophil gelatinase-associated lipocalin in immune tolerance induction","volume":"20","author":"Donadei","year":"2018","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.humimm.2024.110792_b0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.humimm.2003.08.347","article-title":"The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability","volume":"64","author":"Rousseau","year":"2003","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels","volume":"55","author":"Hviid","year":"2003","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-0378(99)00035-2","article-title":"Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types","volume":"43","author":"Lefebvre","year":"1999","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110792_b0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","article-title":"IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes","volume":"11","author":"Moreau","year":"1999","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2024.110792_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humrep\/dei305","article-title":"Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro","volume":"21","author":"Yie","year":"2006","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0897.2007.00512.x","article-title":"Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress","volume":"58","author":"Arck","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0110","doi-asserted-by":"crossref","unstructured":"Zhou, X., et al., A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia. Am J Obstet Gynecol, 2012. 206(5): p. 447 e7-16.","DOI":"10.1016\/j.ajog.2012.03.013"},{"issue":"4","key":"10.1016\/j.humimm.2024.110792_b0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.humimm.2006.10.016","article-title":"Hypoxia modulates HLA-G gene expression in tumor cells","volume":"68","author":"Mouillot","year":"2007","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2567.2005.02224.x","article-title":"Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways","volume":"116","author":"Le Rond","year":"2005","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1073\/pnas.0337539100","article-title":"HLA-G gene repression is reversed by demethylation","volume":"100","author":"Moreau","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0130","doi-asserted-by":"crossref","first-page":"e1008805","DOI":"10.1080\/2162402X.2015.1008805","article-title":"Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma","volume":"4","author":"Jasinski-Bergner","year":"2015","journal-title":"Oncoimmunology"},{"issue":"18","key":"10.1016\/j.humimm.2024.110792_b0135","doi-asserted-by":"crossref","first-page":"26866","DOI":"10.18632\/oncotarget.8567","article-title":"Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma","volume":"7","author":"Jasinski-Bergner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2024.110792_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104643","article-title":"Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma","volume":"120","author":"Tan","year":"2021","journal-title":"Exp. Mol. Pathol."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humimm.2009.07.028","article-title":"In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes","volume":"70","author":"Castelli","year":"2009","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0150","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.4049\/jimmunol.1501550","article-title":"HNRNPR regulates the expression of classical and nonclassical MHC class I proteins","volume":"196","author":"Reches","year":"2016","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2024.110792_b0155","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/eji.201343318","article-title":"In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes","volume":"43","author":"Alegre","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0160","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.humimm.2009.07.018","article-title":"Detection of 3-nitrotyrosine-modified human leukocyte antigen-G in biological fluids","volume":"70","author":"Diaz-Lagares","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fimmu.2016.00173","article-title":"The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology","volume":"7","author":"Rebmann","year":"2016","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.humimm.2024.110792_b0170","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.humimm.2024.110792_b0175","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1349-7006.2011.01951.x","article-title":"Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells","volume":"102","author":"Du","year":"2011","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.humimm.2024.110792_b0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3324\/haematol.2014.113803","article-title":"HLA-G expression levels influence the tolerogenic activity of human DC-10","volume":"100","author":"Amodio","year":"2015","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.humimm.2024.110792_b0185","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1182\/blood-2011-07-370742","article-title":"The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells","volume":"118","author":"Carosella","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humimm.2024.110792_b0190","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/humrep\/dev196","article-title":"Soluble human leukocyte antigen G5 polarizes differentiation of macrophages toward a decidual macrophage-like phenotype","volume":"30","author":"Lee","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.humimm.2024.110792_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/636292","article-title":"HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia","volume":"2014","author":"Locafaro","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.humimm.2024.110792_b0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1044-579X(03)00022-1","article-title":"HLA-G modulates immune responses by diverse receptor interactions","volume":"13","author":"Hofmeister","year":"2003","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0205","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4049\/jimmunol.1700737","article-title":"Human M2 macrophages limit NK cell effector functions through secretion of TGF-beta and engagement of CD85j","volume":"200","author":"Nunez","year":"2018","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2024.110792_b0210","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1002\/cti2.1077","article-title":"Intercellular transfer of HLA-G: its potential in cancer immunology","volume":"8","author":"Lin","year":"2019","journal-title":"Clin. Transl. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2024.110792_b0215","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2012-03-416792","article-title":"CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis","volume":"120","author":"Brown","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2024.110792_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-015-0114-8","article-title":"Trogocytic intercellular membrane exchanges among hematological tumors","volume":"8","author":"LeMaoult","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110792_b0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","article-title":"Trogocytosis-based generation of suppressive NK cells","volume":"26","author":"Caumartin","year":"2007","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124362","article-title":"NKG2A\/CD94 is a new immune receptor for HLA-G and distinguishes amino acid differences in the HLA-G heavy chain","volume":"21","author":"Ho","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1095\/biolreprod.104.037986","article-title":"HLA-G*0105N null allele encodes functional HLA-G isoforms","volume":"73","author":"Le Discorde","year":"2005","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0240","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.humimm.2003.12.004","article-title":"Truncated HLA-G isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands","volume":"65","author":"Ulbrecht","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0245","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3389\/fimmu.2020.01349","article-title":"The role of HLA-G in human papillomavirus infections and cervical carcinogenesis","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0250","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fimmu.2020.01178","article-title":"HLA-G genotype\/expression\/disease association studies: Success, hurdles, and perspectives","volume":"11","author":"Amodio","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0255","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3389\/fimmu.2020.01685","article-title":"HLA-G neo-expression on tumors","volume":"11","author":"Loustau","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2024.110792_b0260","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2119\/molmed.2015.00083","article-title":"Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy","volume":"21","author":"Lin","year":"2015","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0265","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00432-022-04493-1","article-title":"HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events","volume":"149","author":"Jiang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.humimm.2024.110792_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158265","article-title":"A critical assessment of the association between HLA-G expression by carcinomas and clinical outcome","volume":"22","author":"van de Water","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2024.110792_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.796054","article-title":"HLA-G: Too much or too little? Role in cancer and autoimmune disease","volume":"13","author":"Martin-Villa","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2024.110792_b0280","doi-asserted-by":"crossref","first-page":"e1342023","DOI":"10.1080\/2162402X.2017.1342023","article-title":"Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G\/ILT2\/ILT4","volume":"6","author":"Rouas-Freiss","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humimm.2024.110792_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811200","article-title":"The human leukocyte antigen G as an immune escape mechanism and novel therapeutic target in urological tumors","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2024.110792_b0290","first-page":"1954","article-title":"Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies","volume":"59","author":"Paul","year":"1999","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tan.14334","article-title":"HLA-G expression correlates with histological grade but not with prognosis in colorectal carcinoma","volume":"98","author":"Kaprio","year":"2021","journal-title":"HLA"},{"key":"10.1016\/j.humimm.2024.110792_b0300","article-title":"Systematic evaluation of HLA-G 3'Untranslated region variants in locally advanced, non-metastatic breast cancer patients: UTR-1, 2 or UTR-4 are predictors for therapy and disease outcome","volume":"12","author":"Rebmann","year":"2021","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.humimm.2024.110792_b0305","first-page":"6838","article-title":"Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma","volume":"61","author":"Ibrahim","year":"2001","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.2009.01302.x","article-title":"Characterization of HLA-G expression in renal cell carcinoma","volume":"74","author":"Li","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2024.110792_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826074","article-title":"Role of HLA-G in viral infections","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0320","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1152\/ajpendo.00140.2004","article-title":"Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women","volume":"288","author":"Dick","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0325","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00418-022-02141-w","article-title":"HLA-G as a prognostic marker in stage II\/III colorectal cancer: not quite there yet","volume":"158","author":"Gambella","year":"2022","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.humimm.2024.110792_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.698438","article-title":"HLA-G 3'UTR polymorphisms are linked to susceptibility and survival in Spanish gastric adenocarcinoma patients","volume":"12","author":"Vaquero-Yuste","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110792_b0335","doi-asserted-by":"crossref","first-page":"e0175128","DOI":"10.1371\/journal.pone.0175128","article-title":"Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors","volume":"12","author":"Martinez-Canales","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124528","article-title":"HLA-G: A new immune checkpoint in cancer?","volume":"21","author":"Krijgsman","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2024.110792_b0345","article-title":"HLA-G\/ILTs targeted solid cancer immunotherapy: Opportunities and challenges","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0350","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/274584","article-title":"HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas","volume":"2014","author":"Rutten","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0355","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2007.06.012","article-title":"Clinical and biological significance of HLA-G expression in ovarian cancer","volume":"17","author":"Sheu","year":"2007","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0360","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.oooo.2016.12.002","article-title":"Evaluation of HLA-G, HLA-E, and PD-L1 proteins in oral osteosarcomas","volume":"123","author":"Costa Arantes","year":"2017","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.humimm.2024.110792_b0365","article-title":"Prognostic significance of immune checkpoints HLA-G\/ILT-2\/4 and PD-L1 in colorectal cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2024.110792_b0370","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.humimm.2016.04.006","article-title":"Role of microRNAs on HLA-G expression in human tumors","volume":"77","author":"Seliger","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0375","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.scr.2017.01.005","article-title":"The role of methylation, DNA polymorphisms and microRNAs on HLA-G expression in human embryonic stem cells","volume":"19","author":"Verloes","year":"2017","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.humimm.2024.110792_b0380","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3892\/ol.2022.13347","article-title":"Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer","volume":"24","author":"Emirzeoglu","year":"2022","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molimm.2015.01.030","article-title":"MicroRNAs targeting the immunomodulatory HLA-G gene: A new survey searching for microRNAs with potential to regulate HLA-G","volume":"65","author":"Porto","year":"2015","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0390","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/ijo.2016.3589","article-title":"Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer","volume":"49","author":"Sun","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.humimm.2024.110792_b0395","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40425-016-0184-3","article-title":"Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases","volume":"4","author":"Ferns","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0400","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.24852","article-title":"The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer","volume":"126","author":"Bijen","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0405","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)63844-8","volume":"162","author":"Ibrahim","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"6024","key":"10.1016\/j.humimm.2024.110792_b0410","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.humimm.2024.110792_b0415","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0420","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","article-title":"Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule","volume":"16","author":"Lozano","year":"2002","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0425","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.164.12.6426","article-title":"Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection","volume":"164","author":"Onno","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0430","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/693643","article-title":"HLA-G\/C, miRNAs, and their role in HIV infection and replication","volume":"2013","author":"Celsi","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.humimm.2024.110792_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104580","article-title":"The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?","volume":"85","author":"Rashidi","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0440","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.humimm.2014.09.019","article-title":"Non-classical MHC-I human leukocyte antigen (HLA-G) in hepatotropic viral infections and in hepatocellular carcinoma","volume":"75","author":"Catamo","year":"2014","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0445","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2893.2010.01286.x","article-title":"Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection","volume":"18","author":"Souto","year":"2011","journal-title":"J. Viral Hepat."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0450","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.humimm.2009.07.026","article-title":"Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection","volume":"70","author":"LeBouder","year":"2009","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2024.110792_b0455","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122608","article-title":"The U94 gene of human herpesvirus 6: A narrative review of its role and potential functions","volume":"9","author":"Caselli","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2024.110792_b0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fonc.2019.00058","article-title":"Immune modulation in HLA-G expressing head and neck squamous cell carcinoma in relation to human papilloma virus positivity: A study from Northeast India","volume":"9","author":"Sarmah","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2024.110792_b0465","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-021-06079-7","article-title":"HLA-G polymorphism impacts the outcome of oral HPV infections in women","volume":"21","author":"Jaakola","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.humimm.2024.110792_b0470","doi-asserted-by":"crossref","first-page":"e0204679","DOI":"10.1371\/journal.pone.0204679","article-title":"Variation sites at the HLA-G 3' untranslated region confer differential susceptibility to HIV\/HPV co-infection and aneuploidy in cervical cell","volume":"13","author":"Medeiros","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2024.110792_b0475","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13027-018-0217-2","article-title":"Association of HLA-G 3' UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections","volume":"13","author":"Xu","year":"2018","journal-title":"Infect. Agent Cancer"},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0480","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejca.2013.10.018","article-title":"Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women","volume":"50","author":"Yang","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.humimm.2024.110792_b0485","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/1471-2407-12-618","article-title":"Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis","volume":"12","author":"Gillio-Tos","year":"2012","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.humimm.2024.110792_b0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10096-021-04362-8","article-title":"The association of HLA-G polymorphism with oral and genital HPV infection in men","volume":"41","author":"Suominen","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.humimm.2024.110792_b0495","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1002\/iid3.645","article-title":"The relationship of 3'UTR HLA-G14-bp insertion\/deletion and +3142 C\/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis","volume":"10","author":"Tizaoui","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.humimm.2024.110792_b0500","doi-asserted-by":"crossref","first-page":"1138559","DOI":"10.3389\/fimmu.2023.1138559","article-title":"A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G","volume":"14","author":"Mocci","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0505","doi-asserted-by":"crossref","first-page":"2728757","DOI":"10.1155\/2021\/2728757","article-title":"Identification of differentially expressed genes in COVID-19 and integrated bioinformatics analysis of signaling pathways","volume":"2021","author":"Fang","year":"2021","journal-title":"Genet. Res. (Camb.)"},{"issue":"11","key":"10.1016\/j.humimm.2024.110792_b0510","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00018-022-04592-9","article-title":"Induction of pulmonary HLA-G expression by SARS-CoV-2 infection","volume":"79","author":"Seliger","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.humimm.2024.110792_b0515","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.humimm.2021.07.007","article-title":"Soluble HLA-G is upregulated in serum of patients with severe COVID-19","volume":"82","author":"Al-Bayatee","year":"2021","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2024.110792_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/v13091855","article-title":"Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion","volume":"13","author":"Bortolotti","year":"2021","journal-title":"Viruses"},{"issue":"17","key":"10.1016\/j.humimm.2024.110792_b0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179736","article-title":"The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule","volume":"23","author":"Cordeiro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.humimm.2024.110792_b0530","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41423-020-0450-7","article-title":"NKG2A and COVID-19: another brick in the wall","volume":"17","author":"Antonioli","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110792_b0535","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1002\/cti2.1128","article-title":"Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence","volume":"9","author":"Zhang","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105550","article-title":"The association of decreased HLA-G(+) immune cell frequencies with critical COVID-19 patients","volume":"167","author":"Ramzannezhad","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.humimm.2024.110792_b0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788769","article-title":"Perspective of HLA-G induced immunosuppression in SARS-CoV-2 infection","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110792_b0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2021.06.018","article-title":"Tumor infiltrating and peripheral CD4(+)ILT2(+) T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients","volume":"519","author":"Jacquier","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.humimm.2024.110792_b0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001998","article-title":"First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G","volume":"9","author":"Anna","year":"2021","journal-title":"J. Immunother. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:02:28Z","timestamp":1781568148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0198885924000521"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110792","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of HLA-G in tumors and upon COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"110792"}}